brexit_istock-531915594_altamira83
altamira83 / iStockphoto.com
17 January 2019Big Pharma

Life sciences lawyers shocked and concerned amid Brexit uncertainty

Lawyers have told LSIPR they are concerned about the continuing UK political uncertainty having a negative impact on life sciences investment and the Unified Patent Court (UPC).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
27 June 2019   Industry has welcomed the British government’s announcement that it will take steps to secure additional freight capacity to deal with a shortage of pharmaceuticals in the event of a no-deal Brexit.
Big Pharma
8 January 2019   The UK government has published further guidance on the regulation of medicines, medical devices and clinical trials in the event of a no-deal Brexit.
Big Pharma
12 November 2018   Associations representing the pharmaceutical and biotechnology fields have said that the UK should maintain “close cooperation” with the EU post-Brexit, to ensure that access to safe and effective medicines continues in both markets.